34131267|t|Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis.
34131267|a|Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can exert antidepressant, anti-inflammatory and neuroprotective properties, but the exact molecular mechanism underlying their effects is still not fully understood. We conducted both in vitro and clinical investigations to test which EPA or DHA metabolites are involved in these anti-inflammatory, neuroprotective and antidepressant effects. In vitro, we used the human hippocampal progenitor cell line HPC0A07/03C, and pre-treated cells with either EPA or DHA, followed by interleukin 1beta (IL1beta), IL6 and interferon-alpha (IFN-alpha). Both EPA and DHA prevented the reduction in neurogenesis and the increase in apoptosis induced by these cytokines; moreover, these effects were mediated by the lipoxygenase (LOX) and cytochrome P450 (CYP450) EPA/DHA metabolites, 5-hydroxyeicosapentaenoic acid (HEPE), 4-hydroxydocosahexaenoic acid (HDHA), 18-HEPE, 20-HDHA, 17(18)-epoxyeicosatetraenoic acid (EpETE) and 19(20)-epoxydocosapentaenoic acid (EpDPA), detected here for the first time in human hippocampal neurones using mass spectrometry lipidomics of the supernatant. In fact, like EPA/DHA, co-treatment with these metabolites prevented cytokines-induced reduction in neurogenesis and apoptosis. Moreover, co-treatment with 17(18)-EpETE and 19(20)-EpDPA and the soluble epoxide hydroxylase (sEH) inhibitor, TPPU (which prevents their conversion into dihydroxyeicosatetraenoic acid (DiHETE)/ dihydroxydocosapentaenoic acid (DiHDPA) metabolites) further enhanced their neurogenic and anti-apoptotic effects. Interestingly, these findings were replicated in a sample of n = 22 patients with a DSM-IV Major Depressive Disorder, randomly assigned to treatment with either EPA (3.0 g/day) or DHA (1.4 g/day) for 12 weeks, with exactly the same LOX and CYP450 lipid metabolites increased in the plasma of these patients following treatment with their precursor, EPA or DHA, and some evidence that higher levels of these metabolites were correlated with less severe depressive symptoms. Overall, our study provides the first evidence for the relevance of LOX- and CYP450-derived EPA/DHA bioactive lipid metabolites as neuroprotective molecular targets for human hippocampal neurogenesis and depression, and highlights the importance of sEH inhibitors as potential therapeutic strategy for patients suffering from depressive symptoms.
34131267	0	35	Omega-3 polyunsaturated fatty acids	Chemical	-
34131267	52	64	inflammation	Disease	MESH:D007249
34131267	102	107	lipid	Chemical	MESH:D008055
34131267	133	149	major depression	Disease	MESH:D003865
34131267	158	163	human	Species	9606
34131267	190	211	Eicosapentaenoic acid	Chemical	MESH:D015118
34131267	213	216	EPA	Chemical	MESH:D015118
34131267	222	242	docosahexaenoic acid	Chemical	MESH:D004281
34131267	244	247	DHA	Chemical	MESH:D004281
34131267	259	273	antidepressant	Disease	
34131267	280	292	inflammatory	Disease	MESH:D007249
34131267	484	487	EPA	Chemical	MESH:D015118
34131267	491	494	DHA	Chemical	MESH:D004281
34131267	534	546	inflammatory	Disease	MESH:D007249
34131267	614	619	human	Species	9606
34131267	653	664	HPC0A07/03C	CellLine	CVCL:9T02
34131267	700	703	EPA	Chemical	MESH:D015118
34131267	707	710	DHA	Chemical	MESH:D004281
34131267	724	741	interleukin 1beta	Gene	3553
34131267	743	750	IL1beta	Gene	3553
34131267	753	756	IL6	Gene	3569
34131267	779	788	IFN-alpha	Gene	3439
34131267	796	799	EPA	Chemical	MESH:D015118
34131267	804	807	DHA	Chemical	MESH:D004281
34131267	999	1002	EPA	Chemical	MESH:D015118
34131267	1003	1006	DHA	Chemical	MESH:D004281
34131267	1020	1050	5-hydroxyeicosapentaenoic acid	Chemical	MESH:C058722
34131267	1052	1056	HEPE	Chemical	MESH:C058722
34131267	1059	1088	4-hydroxydocosahexaenoic acid	Chemical	MESH:C526920
34131267	1090	1094	HDHA	Chemical	MESH:C526920
34131267	1097	1104	18-HEPE	Chemical	-
34131267	1106	1113	20-HDHA	Chemical	-
34131267	1115	1148	17(18)-epoxyeicosatetraenoic acid	Chemical	MESH:C070378
34131267	1150	1155	EpETE	Chemical	-
34131267	1161	1194	19(20)-epoxydocosapentaenoic acid	Chemical	MESH:C000718051
34131267	1196	1201	EpDPA	Chemical	-
34131267	1240	1245	human	Species	9606
34131267	1336	1339	EPA	Chemical	MESH:D015118
34131267	1340	1343	DHA	Chemical	MESH:D004281
34131267	1478	1490	17(18)-EpETE	Chemical	-
34131267	1495	1507	19(20)-EpDPA	Chemical	-
34131267	1516	1543	soluble epoxide hydroxylase	Gene	2053
34131267	1545	1548	sEH	Gene	2053
34131267	1561	1565	TPPU	Chemical	-
34131267	1604	1634	dihydroxyeicosatetraenoic acid	Chemical	-
34131267	1636	1642	DiHETE	Chemical	-
34131267	1645	1675	dihydroxydocosapentaenoic acid	Chemical	-
34131267	1677	1683	DiHDPA	Chemical	-
34131267	1828	1836	patients	Species	9606
34131267	1844	1850	DSM-IV	Disease	MESH:D006011
34131267	1851	1876	Major Depressive Disorder	Disease	MESH:D003865
34131267	1921	1924	EPA	Chemical	MESH:D015118
34131267	1940	1943	DHA	Chemical	MESH:D004281
34131267	2007	2012	lipid	Chemical	MESH:D008055
34131267	2058	2066	patients	Species	9606
34131267	2109	2112	EPA	Chemical	MESH:D015118
34131267	2116	2119	DHA	Chemical	MESH:D004281
34131267	2212	2231	depressive symptoms	Disease	MESH:D003866
34131267	2325	2328	EPA	Chemical	MESH:D015118
34131267	2329	2332	DHA	Chemical	MESH:D004281
34131267	2343	2348	lipid	Chemical	MESH:D008055
34131267	2402	2407	human	Species	9606
34131267	2437	2447	depression	Disease	MESH:D003866
34131267	2482	2485	sEH	Gene	2053
34131267	2535	2543	patients	Species	9606
34131267	2559	2578	depressive symptoms	Disease	MESH:D003866
34131267	Positive_Correlation	MESH:C058722	MESH:D015118
34131267	Association	MESH:D008055	MESH:D003865
34131267	Association	MESH:C070378	MESH:D015118
34131267	Association	MESH:C058722	MESH:D004281
34131267	Association	MESH:D008055	MESH:D007249
34131267	Negative_Correlation	MESH:D004281	MESH:D007249
34131267	Association	MESH:C070378	MESH:D004281
34131267	Comparison	MESH:D004281	MESH:D015118
34131267	Association	MESH:C000718051	MESH:D004281
34131267	Negative_Correlation	MESH:D015118	MESH:D007249
34131267	Positive_Correlation	MESH:C000718051	MESH:D015118
34131267	Association	MESH:C526920	MESH:D004281
34131267	Positive_Correlation	MESH:C526920	MESH:D015118

